BrainCool AB (publ) (STO:BRAIN)
Sweden
· Delayed Price · Currency is SEK 1.684
-0.056 (-3.22%)
May 13, 2025, 5:29 PM CET
BrainCool AB Revenue
BrainCool AB had revenue of 11.40M SEK in the quarter ending March 31, 2025, with 21.04% growth. This brings the company's revenue in the last twelve months to 44.68M, up 34.64% year-over-year. In the year 2024, BrainCool AB had annual revenue of 42.69M with 55.79% growth.
Revenue (ttm)
44.68M
Revenue Growth
+34.64%
P/S Ratio
9.55
Revenue / Employee
2.23M
Employees
21
Market Cap
426.71M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 42.69M | 15.29M | 55.79% |
| Dec 31, 2023 | 27.40M | -2.65M | -8.81% |
| Dec 31, 2022 | 30.05M | 6.58M | 28.01% |
| Dec 31, 2021 | 23.48M | 7.52M | 47.14% |
| Dec 31, 2020 | 15.96M | 4.15M | 35.17% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Swedish Orphan Biovitrum AB | 26.24B |
| Sectra AB | 3.30B |
| Getinge AB | 35.57B |
| Camurus AB | 1.87B |
| Medicover AB | 23.56B |
| AddLife AB | 10.42B |
| Vitrolife AB | 3.61B |
| Vimian Group AB | 4.24B |